Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Zhejiang Cancer Hospital)"
Count: 271
Selected: 0
NCT02385136Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
NCT02992067CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
NCT01258192Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients
NCT01915134Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT01536223Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma
NCT02702323Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study
NCT02597868A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
NCT04189094Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC
NCT05794841Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract
NCT04543890A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC
NCT05651802PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients
NCT05126160Immune Score Based Radiomics in Nasopharyngeal Carcinoma
NCT03015727Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
NCT05007587Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC
NCT01733589Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
NCT05183958A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
NCT05896059A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
NCT05856383Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
NCT05813626Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05705583A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
NCT05669807Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
NCT05669092A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status
NCT05652192SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
NCT05617469DLCS for Predicting Neoadjuvant Chemotherapy Response
NCT05596071Whether Opioids Are Factor That Induced POD?
NCT05564897Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer
NCT05559775A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy
NCT05557578GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence
NCT05550090Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
NCT05544149TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors
NCT05528367Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
NCT05514275Radiotherapy Combined With Endostatin and Capecitabine for NPC
NCT05507411Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
NCT05502458Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor
NCT05489926A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
NCT05480189Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study
NCT05468671Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy
NCT05448638Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery
NCT05410444The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer
NCT05387044SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors
NCT05385809A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer
NCT05322499Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
NCT05298319The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy
NCT05290090ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL
NCT05269056Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05247619A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
NCT05242861Retrospective Study of Brachytherapy
NCT05234905H101 Combined With Camrelizumab for Recurrent Cervical Cancer
NCT05232552Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma